The partnership between UCSF and Pfizer’s Center for Therapeutic Innovation (CTI) began in 2010, serving as the model for many industry-university partnerships that emerged across the country in later years. Together, UCSF and Pfizer CTI identify and execute research collaborations that 1) accelerate the discovery and development of innovative antibody drugs or 2) identify potential new small molecules against novel disease targets. Pfizer CTI has funded many projects at UCSF to date, and Pfizer continues to partner with UCSF by other mechanisms as well. (2017 Press Release)